Skip to content
IDIBELL
  • Donate!
  • Contact
  • Intranet
  • En
    • Ca
    • Es
Below Header
  • The Institute
  • Research
  • Services
  • Innovation
  • News & Events
  • Scientific culture
  • Home
  • Cancer
  • Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell
  • Neuro-Oncology

Neuro-Oncology

02/04/2025

Dr. Roser Velasco, co-lead author of an international guideline on the management of neurological complications in CAR-T cell treatments

27/09/2024

Bellvitge leads the creation of a new, more precise tool to assess chemotherapy-induced neurological toxicity

12/03/2024

A new tool based on Artificial Intelligence will improve brain tumour diagnosis

22/08/2023

First clinical trial of a treatment that attacks lung cancer and brain metastasis at the same time

17/02/2023

The diagnosis and treatment of glioblastoma during the 2008 financial crisis and the COVID-19 pandemic

24/11/2021

The activation of a key protein completes the process of death by apoptosis in glioblastoma cells

03/06/2021

Exercise prevents neuronal damage caused by lung cancer treatment

30/03/2021

Researchers define the clinical characteristics of the cerebral complications caused by oncological immunotherapies that determine the evolution

29/09/2020

Identified the cellular process by which Cisplatin chemotherapy causes neuronal damage

09/10/2019

Oligodendroglial brain tumor survivors run the risk of developing long-term cognitive impairment

  • 1
  • 2
  • Next »

Direct links

  • Comittees and boards
  • Transparency
  • Complaints channel
  • Channel against discrimination and harassment
  • Legal notice
  • Privacy Policy
  • Privacy policy social networks

Follow us

  • 𝕏
  • Facebook
  • Youtube
  • Linkedin
  • Instagram

Contact

+34 93 607 38 00
info@idibell.cat

Localization

Hospital Duran i Reynals
2a planta Edifici Terapèutic
Av. Granvia de l’Hospitalet, 199
08908 L’Hospitalet de Llobregat (Barcelona)

IDIBELL
Copyright © 2025 Institut d’Investigació Biomèdica de Bellvitge
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Funcional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
Scroll to Top